Conditions: Human Papillomavirus (HPV) Type 16/18 Infections; Cervical Neoplasia
Intervention: Biological: GSK580299 (CervarixTM)
Sponsor: GlaxoSmithKline
Not yet recruiting - verified August 2010
Feeds
4318 items (4318 unread) in 87 feeds
Acinar Cell Carcinoma
(24 unread)
Acinic Cell Carcinoma
(33 unread)
Adenoid Cystic Carcinoma
(83 unread)
Adrenal Gland Cancer
(305 unread)
Ampulla Of Vater
(23 unread)
Anal Cancer
(212 unread)
Angiosarcoma
(79 unread)
Appendix Cancer
(66 unread)
Bile Duct Cancer
(332 unread)
Brain and CNS
(1194 unread)
Carcinoid
(124 unread)
Endocrine/Neuroendocrine
(500 unread)
Gall Bladder Cancer
(89 unread)
General
(4 unread)
Hemangioendothelioma
(38 unread)
HemeOnc
(78 unread)
Hepatoblastoma
(46 unread)
Pancreas
(76 unread)
Phyllodes
(21 unread)
PMP and Mucinous Tumors
(35 unread)
Rhabdomyosarcoma
(175 unread)
Sarcoma
(313 unread)
Twitter Pals
(468 unread)
Trial - Adrenal Cancer (63 unread)
-
Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study
Posted: August 26th, 2010, 9:00am CDT
-
Arterial Stiffness Index as a Predictor of Surgically Correctable Primary Aldosteronism
Posted: August 25th, 2010, 9:00am CDT
Condition: Aortic Stiffness is a Predictor of Blood Pressure Response After Surgery in Patients With Aldosterone Producing Adenoma.
Intervention: Device: complier device
Sponsor: University Hospital, Toulouse
Recruiting - verified August 2010 -
Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer
Posted: August 18th, 2010, 9:00am CDT
Conditions: Non-Small-Cell Lung Carcinoma; Liver Cancer; Adrenal Cancer
Intervention: Radiation: stereotactic body radiation therapy
Sponsor: Wake Forest University
Recruiting - verified August 2010 -
A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers
Posted: March 12th, 2010, 9:00am CST
Conditions: Breast Cancer; Lung Cancer; Renal Cancer; Adrenal Cancer
Intervention: Drug: F-18 Paclitaxel (FPAC)
Sponsor: National Cancer Institute (NCI)
Recruiting - verified February 2010 -
Seneca Valley Virus-001 in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features
Posted: January 13th, 2010, 9:00am CST
Conditions: Adrenocortical Carcinoma; Gastrointestinal Carcinoid Tumor; Kidney Cancer; Neuroblastoma; Retinoblastoma; Sarcoma
Interventions: Biological: Seneca Valley virus-001; Other: laboratory biomarker analysis; Other: pharmacological study
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified August 2010 -
Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders
Posted: January 5th, 2010, 9:00am CST
Conditions: Mucopolysaccharidosis; Hurler Syndrome; Hunter Syndrome; Maroteaux-Lamy Syndrome; Sly Syndrome; Alpha Mannosidosis; Fucosidosis; Aspartylglucosaminuria; Adrenoleukodystrophy; Globoid Cell Leukodystrophy; Krabbe Disease; Sphingolipidoses; Peroxisomal Disorders
Interventions: Drug: Campath-1H; Drug: Cyclophosphamide; Drug: Busulfan; Procedure: Allogeneic stem cell transplantation
Sponsor: Masonic Cancer Center, University of Minnesota
Recruiting - verified July 2010 -
Study of Vorinostat and Gefitinib in Relapsed/ or Refractory Patients With Advanced Non-small Cell Carcinoma (NSCLC)
Posted: December 8th, 2009, 9:00am CST
Condition: Non-Small-Cell Lung Carcinoma
Intervention: Drug: Study treatment
Sponsors: National Cancer Center, Korea; Merck
Recruiting - verified July 2010 -
Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Posted: October 30th, 2009, 9:00am CDT
Conditions: Neuroendocrine Neoplasms; Thyroid Neoplasms; Parathyroid Neoplasms; Adrenal Neoplasm; Neuroblastoma
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting - verified August 2010 -
A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors
Posted: July 23rd, 2009, 9:00am CDT
Conditions: Neuroendocrine Tumors; Neuroendocrine Tumors Carcinoid Tumors; Neuroendocrine Tumors Islet Cell Tumors (Pancreatic Neuroendocrine Tumors); Neuroendocrine Tumors Adrenal Gland Tumors; Neuroendocrine Tumors Multiple Endocrine Neoplasia, Type 1/2; Neuroendocrine Tumors Neuroblastoma
Interventions: Drug: pertuzumab; Drug: erlotinib
Sponsors: Stanford University; Genentech
Recruiting - verified June 2010 -
A Targeted Phase I/II Trial of ZD6474 (Vandetanib; ZACTIMA) Plus the Proteasome Inhibitor, Bortezomib (Velcade(Registered Trademark)), in Adults With Solid Tumors With a Focus on Hereditary or Sporadic, Locally Advanced or Metastatic Medullary Thyroi...
Posted: June 17th, 2009, 9:00am CDT
Conditions: Breast Cancer; Colon Cancer; Prostate Cancer; Lung Cancer; Adrenal Cancer; Renal Cancer; Gastric Cancer; Ovarian Cancer; Cervical Cancer; Thyroid Cancer; Sarcoma
Interventions: Drug: VELCADE, PS-341 (Bortezomib, NSC #681239); Drug: ZACTIMA (Vandetanib) (ZD6474)
Sponsor: National Cancer Institute (NCI)
Recruiting - verified December 2009 -
International Study: Comparison of Two Treatments for Adrenocortical Cancer
Posted: June 17th, 2009, 9:00am CDT
Condition: Adenocortical
Interventions: Drug: Mitotane; Drug: Streptozocin; Drug: Doxorubicin; Drug: Etoposide; Drug: Cisplatin
Sponsor: National Cancer Institute (NCI)
Active, not recruiting - verified March 2010 -
Study of OSI-906 in Patients With Locally Advanced or Metastatic Adrenocortical Carcinoma
Posted: June 17th, 2009, 9:00am CDT
Condition: Adrenocortical Carcinoma (ACC)
Interventions: Drug: OSI-906; Other: Placebo
Sponsor: OSI Pharmaceuticals
Recruiting - verified July 2010 -
Optical Tomography With Ultrasound Guidance
Posted: May 22nd, 2009, 9:00am CDT
Condition: Breast Cancer
Intervention:
Sponsors: University of Connecticut Health Center; National Institute for Biomedical Imaging and Bioengineering (NIBIB); Donaghue Medical Research Foundation
Recruiting - verified June 2010 -
Fatigue in Healthy Individuals
Posted: April 24th, 2009, 9:00am CDT
Conditions: Healthy Volunteer; Fatigue; Depression
Intervention:
Sponsor: National Institute of Nursing Research (NINR)
Recruiting - verified February 2010 -
Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors
Posted: April 6th, 2009, 9:00am CDT
Condition: Central Nervous System Tumors
Interventions: Drug: Bevacizumab; Drug: Irinotecan; Drug: Temozolomide
Sponsors: All Children's Hospital; V Foundation
Recruiting - verified October 2009 -
Gossypol Acetic Acid in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery
Posted: February 19th, 2009, 9:00am CST
Condition: Adrenocortical Carcinoma
Intervention: Drug: R-(-)-gossypol acetic acid
Sponsors: Mayo Clinic; National Cancer Institute (NCI)
Recruiting - verified May 2010 -
Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
Posted: January 28th, 2009, 9:00am CST
Conditions: Adrenocortical Carcinoma; Kidney Cancer; Liver Cancer; Neuroblastoma; Retinoblastoma; Sarcoma
Interventions: Biological: cixutumumab; Other: laboratory biomarker analysis
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified August 2010 -
Epidemiological Study to Describe NSCLC Clinical Management Patterns in Europe. Lung-EPICLIN
Posted: January 28th, 2009, 9:00am CST
Condition: NSCLC
Intervention:
Sponsor: AstraZeneca
Completed - verified August 2010 -
Mitotane With or Without IMC-A12 in Treating Patients With Recurrent, Metastatic, or Primary Adrenocortical Cancer That Cannot Be Removed By Surgery
Posted: October 22nd, 2008, 9:00am CDT
Condition: Adrenocortical Carcinoma
Interventions: Biological: cixutumumab; Drug: mitotane
Sponsors: University of Chicago; National Cancer Institute (NCI)
Recruiting - verified August 2010 -
Patients Overexposed for a Prostate Adenocarcinoma
Posted: October 15th, 2008, 9:00am CDT
Condition: Prostate Adenocarcinoma
Intervention: Other: Whole blood sample
Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting - verified May 2010 -
Follow-Up Study for Exubera
Posted: August 12th, 2008, 9:00am CDT
Condition: Diabetes Mellitus
Interventions: Drug: Exubera; Other: Randomized diabetes therapy
Sponsor: Pfizer
Recruiting - verified August 2010 -
Insulin Sensitivity and Substrate Metabolism in Patients With Cushing's Syndrome
Posted: May 20th, 2008, 9:00am CDT
Conditions: Cushing's Syndrome; Insulin Resistance
Intervention: Procedure: Surgery
Sponsors: University of Aarhus; Aarhus University Hospital
Recruiting - verified June 2010 -
Adrenal Tumors - Pathogenesis and Therapy
Posted: April 28th, 2008, 9:00am CDT
Conditions: Adrenal Tumors; Adrenocortical Carcinoma; Cushing Syndrome; Conn Syndrome; Pheochromocytoma
Intervention:
Sponsors: University of Wuerzburg; Deutsche Krebshilfe e.V., Bonn (Germany); German Federal Ministry of Education and Research
Recruiting - verified July 2010 -
Bone Health Observational Study
Posted: February 20th, 2008, 9:00am CST
Condition: Prostate Cancer
Intervention:
Sponsors: CMX Research; AstraZeneca
Recruiting - verified August 2010 -
Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women
Posted: January 23rd, 2008, 9:00am CST
Condition: Hypoactive Sexual Desire Disorder
Interventions: Drug: testosterone gel; Drug: placebo gel
Sponsor: BioSante Pharmaceuticals
Recruiting - verified August 2010 -
Adrenal Scans With Radioiodine-Labeled Norcholesterol (NP-59)
Posted: December 26th, 2007, 9:00am CST
Conditions: Adrenal Tumors; Adrenal Malignancies; Abnormal Hormonal Secretions; Electrolytes Abnormalities
Intervention: Other: Imaging, Adrenal acans
Sponsor: Memorial Sloan-Kettering Cancer Center
Active, not recruiting - verified June 2010 -
Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome
Posted: December 24th, 2007, 9:00am CST
Condition: Neuroblastoma
Intervention: Other: Tumor and Marrow Markers
Sponsors: Memorial Sloan-Kettering Cancer Center; Southern Illinois University; Spanish National Cancer Center
Recruiting - verified June 2010 -
Spectroscopy With Surface Coils and Decoupling
Posted: December 20th, 2007, 9:00am CST
Conditions: Adrenal Cortical Cancer; Brain Cancer; Breast Cancer; CNS Cancer; Colon Cancer; HEENT Cancer; Hodgkin's Disease; Kaposi's Sarcoma; Liver Cancer; Lung Cancer; Non-Hodgkin's Lymphoma; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer; Rectal Cancer; Renal Cancer; Sarcoma; Squamous Cell Carcinoma; Thyroid Cancer
Interventions: Device: Proton-decoupled 31P MRS at 1.5T; Device: 1H Spectroscopy at 1.5T and 3T
Sponsors: Memorial Sloan-Kettering Cancer Center; Columbia University; University of Pennsylvania; St.George's Hospital (England); Royal Marsden NHS Foundation Trust; University Medical Center Nijmegen; Weill Medical College of Cornell University
Recruiting - verified June 2010 -
A Trial of Homeopathic Medication TRAUMEEL S for the Treatment of Radiation-Induced Mucositis
Posted: December 20th, 2007, 9:00am CST
Conditions: Mucositis; Head and Neck Cancer
Interventions: Drug: Saline; Drug: Traumeel S; Drug: Traumeel S; Drug: Traumeel S
Sponsor: University of Oklahoma
Active, not recruiting - verified June 2010 -
Evaluation of Side Effects of Mitotane
Posted: December 4th, 2007, 9:00am CST
Condition: Adrenocortical Carcinoma
Intervention:
Sponsor: University of Wuerzburg
Recruiting - verified July 2010 -
Bicalutamide in Treating Patients With Metastatic Breast Cancer
Posted: May 2nd, 2007, 9:00am CDT
Condition: Breast Cancer
Interventions: Drug: bicalutamide; Other: immunohistochemistry staining method; Other: laboratory biomarker analysis
Sponsors: Memorial Sloan-Kettering Cancer Center; National Cancer Institute (NCI)
Recruiting - verified March 2010 -
Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma
Posted: April 4th, 2007, 9:00am CDT
Conditions: Adrenocortical Carcinoma; Cushing's Syndrome
Intervention:
Sponsors: University of Wuerzburg; Deutsche Krebshilfe e.V., Bonn (Germany)
Active, not recruiting - verified July 2010 -
A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone Deficiency
Posted: April 3rd, 2007, 9:00am CDT
Condition: Growth Hormone Disorders
Intervention:
Sponsor: Ipsen
Recruiting - verified July 2010 -
Assessment and Tracking of Long-term Alefacept Safety
Posted: March 29th, 2007, 9:00am CDT
Condition: Psoriasis
Intervention: Drug: Alefacept exposure
Sponsor: Astellas Pharma Inc
Recruiting - verified June 2010 -
German Adrenocortical Carcinoma Registry
Posted: March 28th, 2007, 9:00am CDT
Condition: Adrenocortical Carcinoma
Intervention:
Sponsors: University of Wuerzburg; Deutsche Krebshilfe e.V., Bonn (Germany)
Recruiting - verified July 2010 -
Sunitinib in Refractory Adrenocortical Carcinoma
Posted: March 28th, 2007, 9:00am CDT
Condition: Adrenocortical Carcinoma
Intervention: Drug: Sunitinib
Sponsors: University of Wuerzburg; Pfizer
Active, not recruiting - verified July 2010 -
Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy
Posted: March 28th, 2007, 9:00am CDT
Conditions: Adrenal Tumor; Adrenocortical Carcinoma
Intervention: Drug: 123I-Iodometomidate
Sponsor: University of Wuerzburg
Completed - verified October 2007 -
Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer
Posted: February 15th, 2007, 9:00am CST
Conditions: Peritoneal Neoplasms; Retroperitoneal Neoplasms; Gastrointestinal Neoplasms; Adenocarcinoma; Neuroblastoma; Ovarian Neoplasms; Sarcoma; Adrenocortical Carcinoma; Wilms Tumor; Rhabdomyosarcoma; Desmoplastic Small Round Cell Tumor
Interventions: Drug: CHPP of Cisplatin; Procedure: Abdominal Surgery
Sponsor: M.D. Anderson Cancer Center
Active, not recruiting - verified July 2010 -
Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Posted: January 30th, 2007, 9:00am CST
Condition: Prostate Cancer
Interventions: Drug: docetaxel; Drug: goserelin; Drug: leuprolide acetate; Procedure: conventional surgery
Sponsors: Cancer and Leukemia Group B; National Cancer Institute (NCI); Eastern Cooperative Oncology Group; NCIC Clinical Trials Group
Recruiting - verified August 2010 -
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
Posted: January 12th, 2007, 9:00am CST
Condition: Cushing's Syndrome
Intervention: Drug: Mifepristone
Sponsors: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Laboratoire HRA Pharma
Recruiting - verified June 2010 -
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation
Posted: December 18th, 2006, 9:00am CST
Conditions: Atrial Fibrillation; Atrial Flutter
Interventions: Drug: warfarin; Drug: apixaban
Sponsor: Bristol-Myers Squibb
Active, not recruiting - verified June 2010 -
HSCT for High Risk Inherited Inborn Errors
Posted: September 29th, 2006, 9:00am CDT
Conditions: Adrenoleukodystrophy; Metachromatic Leukodystrophy; Globoid Cell Leukodystrophy; Tay Sachs Disease; Sandhoffs Disease; Wolman Disease; I-Cell Disease; Sanfilippo Syndrome; GM1 Gangliosidosis
Interventions: Drug: Campath; Drug: Clofarabine; Procedure: Total body Irradiation; Drug: Melphalan
Sponsor: Masonic Cancer Center, University of Minnesota
Recruiting - verified July 2010 -
Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP)
Posted: September 6th, 2006, 9:00am CDT
Condition: Purpura, Thrombocytopenic, Idiopathic
Interventions: Drug: Rituximab; Drug: Placebo
Sponsors: Hamilton Health Sciences; Hoffmann-La Roche
Active, not recruiting - verified February 2009 -
Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer
Posted: August 10th, 2006, 9:00am CDT
Condition: Prostate Cancer
Interventions: Biological: gonadotrophin releasing hormone; Drug: cyproterone acetate; Procedure: quality-of-life assessment
Sponsor: St. Bartholomew's Hospital
Recruiting - verified October 2006 -
PET Imaging With Tc-94m Sestamibi to Assess Resistance to Chemotherapy
Posted: July 7th, 2006, 9:00am CDT
Condition: Neoplasms
Interventions: Drug: Tariquidar; Radiation: Tc-94m Sestamibi; Procedure: positron emission tomography; Procedure: radionuclide imaging
Sponsor: National Cancer Institute (NCI)
Suspended - verified October 2009 -
Trial With Taxotere and Cisplatin in Non-operable Adrenocortical Carcinoma
Posted: May 8th, 2006, 9:00am CDT
Condition: Adrenocortical Carcinoma
Intervention: Drug: cisplatin, taxotere
Sponsor: Rigshospitalet, Denmark
Recruiting - verified July 2010 -
Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Posted: March 29th, 2006, 9:00am CST
Condition: Prostate Cancer
Interventions: Drug: antiandrogen therapy; Drug: docetaxel
Sponsors: Eastern Cooperative Oncology Group; National Cancer Institute (NCI)
Recruiting - verified August 2010 -
Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
Posted: March 15th, 2006, 9:00am CST
Condition: Adrenocortical Carcinoma
Interventions: Biological: filgrastim; Biological: pegfilgrastim; Drug: cisplatin; Drug: doxorubicin hydrochloride; Drug: etoposide; Drug: mitotane; Procedure: conventional surgery
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Recruiting - verified August 2010 -
Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older
Posted: February 17th, 2006, 9:00am CST
Condition: Prophylaxis for HPV Infections and Associated Cervical Neoplasia
Interventions: Biological: Cervarix; Biological: Placebo control
Sponsor: GlaxoSmithKline
Active, not recruiting - verified May 2010 -
Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer
Posted: March 3rd, 2005, 9:00am CST
Condition: Prostate Cancer
Interventions: Drug: antiandrogen therapy; Drug: docetaxel; Drug: goserelin; Procedure: orchiectomy
Sponsor: Federation Nationale des Centres de Lutte Contre le Cancer
Active, not recruiting - verified April 2008 -
Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)
Posted: October 19th, 2004, 9:00am CDT
Condition: Carcinoma, Adrenal Cortical
Interventions: Drug: Etoposide; Drug: Doxorubicin; Drug: Cisplatin; Drug: Streptozotocin; Drug: Mitotane
Sponsors: Collaborative Group for Adrenocortical Carcinoma Treatment; German Federal Ministry of Education and Research; National Cancer Institute (NCI)
Active, not recruiting - verified July 2010 -
Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment
Posted: September 7th, 2004, 9:00am CDT
Conditions: Adrenocortical Carcinoma; Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Colorectal Cancer; Extragonadal Germ Cell Tumor; Head and Neck Cancer; Kidney Cancer; Liver Cancer; Neuroblastoma; Ovarian Cancer; Sarcoma
Intervention: Drug: oxaliplatin
Sponsors: Children's Oncology Group; National Cancer Institute (NCI)
Completed - verified September 2006 -
Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse
Posted: March 6th, 2003, 9:00am CST
Condition: Prostate Cancer
Interventions: Drug: bicalutamide; Drug: buserelin; Drug: cyproterone acetate; Drug: docetaxel; Drug: estramustine phosphate sodium; Drug: flutamide; Drug: goserelin; Drug: leuprolide acetate; Drug: nilutamide; Drug: triptorelin; Procedure: conventional surgery; Procedure: neoadjuvant therapy; Radiation: radiation therapy
Sponsor: Federation Nationale des Centres de Lutte Contre le Cancer
Active, not recruiting - verified April 2008 -
Ketoconazole and Docetaxel in Treating Patients With Metastatic Prostate Cancer
Posted: June 6th, 2002, 9:00am CDT
Condition: Prostate Cancer
Interventions: Drug: docetaxel; Drug: ketoconazole
Sponsor: National Cancer Institute (NCI)
Active, not recruiting - verified January 2010 -
Comparison of Megestrol and/or Omega-3 Fatty Acid-Enriched Nutritional Supplement in Treating Patients With Cancer-Related Weight Loss and Lack of Appetite
Posted: March 8th, 2002, 9:00am CST
Conditions: Anorexia; Cachexia
Interventions: Dietary Supplement: omega-3 fatty acid; Drug: megestrol acetate
Sponsors: North Central Cancer Treatment Group; National Cancer Institute (NCI); NCIC Clinical Trials Group
Completed - verified November 2007 -
Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
Posted: October 4th, 2000, 9:00am CDT
Condition: Prostate Cancer
Interventions: Drug: bicalutamide; Drug: flutamide; Drug: goserelin; Drug: leuprolide acetate; Procedure: neoadjuvant therapy; Radiation: brachytherapy; Radiation: iodine I 125; Radiation: palladium Pd 103; Radiation: radiation therapy
Sponsors: Cancer and Leukemia Group B; National Cancer Institute (NCI)
Completed - verified November 2005 -
Study of Adrenal Gland Tumors
Posted: June 28th, 2000, 9:00am CDT
Condition: Adrenal Gland Neoplasm
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified January 2010 -
Diagnosis of Pheochromocytoma
Posted: March 2nd, 2000, 9:00am CST
Condition: Pheochromocytoma
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified June 2010 -
Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex
Posted: November 3rd, 1999, 9:00am CST
Conditions: Cushing's Syndrome; Hereditary Neoplastic Syndrome; Lentigo; Neoplasm; Testicular Neoplasm
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified July 2010 -
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
Posted: November 3rd, 1999, 9:00am CST
Conditions: Abnormalities; Craniopharyngioma; Cushing's Syndrome; Endocrine Disease; Pituitary Neoplasm
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified July 2010 -
New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome
Posted: November 3rd, 1999, 9:00am CST
Condition: Cushing Syndrome
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified November 2009 -
Jugular Vein Sampling for Hormone Levels for the Diagnosis of Cushing Syndrome
Posted: November 3rd, 1999, 9:00am CST
Condition: Cushing's Syndrome
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Active, not recruiting - verified January 2010 -
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
Posted: November 1st, 1999, 9:00am CST
Condition: Colorectal Cancer
Interventions: Drug: FOLFOX regimen; Drug: fluorouracil; Drug: leucovorin calcium; Drug: oxaliplatin
Sponsors: North Central Cancer Treatment Group; National Cancer Institute (NCI); Cancer and Leukemia Group B; NCIC Clinical Trials Group; Eastern Cooperative Oncology Group; Southwest Oncology Group
Completed - verified August 2010